DFBH SEC filings, in plain English
Everything DFB Healthcare Acquisitions Corp. has filed with the SEC that we hold — 40 filings, newest first, 6 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: Exhibit 99.1 to an 8-K of AdaptHealth Corp. (Nasdaq: AHCO): the August 4, 2026 press release reporting Q2 2026 results. Net revenue from continuing operations rose 12.7% to $740.3 million with organic growth of 15.9%, but net loss attributable to AdaptHealth was $145.3 million against net income of $4.2 million, largely from a $144.2 million pre-tax goodwill write-down; Adjusted EBITDA fell 3.2% to $132.0 million. Year-to-date cash flow from operations was $239.0 million against $257.5 million and free cash flow was negative $48.4 million against positive $73.3 million. Why it matters: Of the roughly $200 million cut to Adjusted EBITDA guidance, the company attributes half to a presentation change from the divestiture and half to real cost pressure — $55 million from the capitated contract transition and $30 million from a manufacturer price increase. Free cash flow has turned negative year to date.
What changed: Q2 2026 10-Q of AdaptHealth Corp. (Nasdaq: AHCO). Net revenue was $740,307 thousand for the quarter against $657,100 thousand and $1,420,180 thousand for the six months. Cash fell to $43,289 thousand from $106,136 thousand at December 31, 2025, while current assets held for sale from discontinued operations rose to $168,098 thousand from $36,354 thousand and equipment and other fixed assets to $656,368 thousand from $503,193 thousand; goodwill fell to $2,370,431 thousand from $2,457,627 thousand and total assets were $4,340,869 thousand. Why it matters: Goodwill fell $87.2 million and the accumulated deficit widened $150.0 million over the half-year while debt rose $164 million. The Diabetes Health business now sits in assets held for sale.
What changed: AdaptHealth Corp., the DFB Healthcare Acquisitions Corp. successor, filed an 8-K attaching as Exhibit 2.1 the execution version of an Asset Purchase Agreement between RGH Enterprises, LLC and AdaptHealth Corp., dated July 19, 2026. Confidential portions are omitted and replaced with bracketed markers on the basis that the information is not material and would likely cause competitive harm. Why it matters: An asset purchase at a de-SPAC is a capital-allocation event rather than a SPAC mechanic — there is no trust or redemption right left from the DFBH vehicle. The material caveat is disclosure: the consideration figure and other commercially sensitive terms are redacted from the filed exhibit, so the size of the transaction and whether AdaptHealth is buying or divesting cannot be established from this document. Confidence is reduced accordingly and the accompanying 8-K item text should be checked for the headline terms.
What changed: AdaptHealth Corp., the DFB Healthcare Acquisitions Corp. successor, disclosed that on July 6, 2026 its subsidiary AdaptHealth LLC issued a notice of redemption for all $325,000,000 of its outstanding 6.125% Senior Notes due 2028, at 100% of principal plus accrued and unpaid interest to but excluding the redemption date. Redemption is conditioned on drawing enough under the existing delayed draw term loan to pay the price. The redemption date is expected to be August 1, 2026 with payment on August 3, after which no interest accrues. Why it matters: This is a refinancing rather than a deleveraging: $325 million of 6.125% notes due 2028 are being repaid with a drawdown under an existing delayed draw term loan, so total debt is unchanged and the outcome depends on whether the new facility's floating rate beats the fixed 6.125%. Redeeming at par avoids any call premium. For former DFBH holders the benefit is the removal of a 2028 maturity wall; the risk is swapping fixed-rate debt for floating in an uncertain rate environment.
What changed: AdaptHealth Corp., the DFB Healthcare Acquisitions successor, reported under Item 1.05 that a threat actor gained unauthorised access to its systems and exfiltrated data, and that on June 27, 2026 it determined the incident material given the volume of data at risk. Access reached cloud-based applications including internal patient management and document storage systems and external electronic health record portals. Exfiltrated data includes a stored insurance billing password file plus personally identifiable and protected health information. Why it matters: A formal Item 1.05 materiality determination is the strongest cybersecurity disclosure a registrant can make and triggers regulatory notification obligations under HIPAA and state breach laws, with remediation, notification and litigation costs to follow. The exfiltration of a stored insurance billing password file is the most dangerous element, since it can enable further intrusion or fraudulent billing. The mitigating facts are the absence of Social Security numbers, bank details and card data in the affected systems.
combination deadlinenothing moved · 1 with no prior record of ours
- Combination deadline
- 2028-12-31not matched in this filing
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: AdaptHealth Corp., the successor to DFB Healthcare Acquisitions Corp., noticed its annual meeting for June 18, 2026, record date April 24, 2026, with three items: director elections, ratification of the independent registered public accounting firm for the fiscal year ending December 31, 2026, and a non-binding advisory say-on-pay vote. Why it matters: Routine annual governance with no trust or redemption right remaining from the DFB SPAC. The structural residue worth noting is that a board designation right granted to the BlueMountain Entities in November 2019, before the de-SPAC, still governs board composition, and the BM Notes remain part of the defined capital structure - legacy sponsor-era agreements that continue to allocate board seats independently of the shareholder vote being solicited here.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.